AU Patent

AU9141391A — Method and systems for administering drugs transdermally using sorbitan esters as skin permeation enhancers

Assigned to Actavis Laboratories UT Inc · Expires 1992-07-08 · 34y expired

What this patent protects

Transdermal delivery systems for delivery of nitroglycerin are disclosed which deliver the drug at enhanced transdermal fluxes. The systems include, in addition to nitroglycerin, a permeation enhancer which is either a sorbitan ester, a C8-C22 aliphatic alcohol, or a mixture ther…

USPTO Abstract

Transdermal delivery systems for delivery of nitroglycerin are disclosed which deliver the drug at enhanced transdermal fluxes. The systems include, in addition to nitroglycerin, a permeation enhancer which is either a sorbitan ester, a C8-C22 aliphatic alcohol, or a mixture thereof. Methods for administering nitroglycerin using such permeation enhancers are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
AU9141391A
Jurisdiction
AU
Classification
—
Expires
1992-07-08
Drug substance claim
No
Drug product claim
No
Assignee
Actavis Laboratories UT Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.